The largest database of trusted experimental protocols

3 protocols using ccr6 pe cy7

1

Polychromatic Flow Cytometry for Treg and Th Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
Regulatory T cells (Treg) were defined as CD4+CD25+CD127low/- cells. Other CD4+T subsets were identified by differential expression of CCR4, CXCR3, and CCR6 as previously reported (7 (link), 9 (link)): CXCR3+CCR4CCR6− (Th1), CXCR3CCR4+CCR6 (Th2), CXCR3CCR4+CCR6+(Th17), and CXCR3+CCR4CCR6+ (Th1Th17) (Figure 1). In addition, Th17 cells were defined as the summation of CXCR3CCR4+CCR6+ (Th17) and CXCR3+CCR4CCR6+(Th1Th17).
The fluorochrome-conjugated antibodies used for polychromatic flow cytometry analysis were CD3-BV510 (Biolegend, USA, catalog no. 317332), CD4-APC-Cy7 (Biolegend, USA, catalog no. 317418), CCR4-APC (Biolegend, USA, catalog no. 359404), CXCR3-PE (Biolegend, USA, catalog no. 353706), CCR6-PE-Cy7 (Biolegend, USA, catalog no. 353418), CD25-BV421 (Biolegend, USA, catalog no. 302630), CD127-FITC (Biolegend, USA, catalog no. 351312), PE-Cy7-CCR7 (Biolegend, USA, catalog no. 353226) and CD62L-FITC (Biolegend, USA, catalog no. 304804). A viability dye, 7-AAD (Becton Dickinson, USA, catalog no. 559925), was used to exclude dead cells. Isotype antibodies were also used as negative controls for every detection to set proper gating for the receptor expression. Cells were analyzed by fluorescence-activated cell sorting (FACS), using the BD LSRII cytometer and FlowJo software.
+ Open protocol
+ Expand
2

Multiparametric T Cell Immunophenotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell surface markers were chosen based on their ability to discriminate subsets in the T cell population of humans. The panel consists of the following antibodies: TCRαβ FITC (Becton Dickinson, Franklin Lakes, NJ), TCRγδ PE (Becton Dickinson, Franklin Lakes, NJ), CD25 ECD (IOTest, Beckman Coulter, Brea, CA), CD4 PERCP (Becton Dickinson, Franklin Lakes, NJ), CCR6 PE-Cy7 (Biolegend, San Diego, CA), CD45RO APC (Becton Dickinson, Franklin Lakes, NJ), IL-23R AF700 (R&D Systems, Minneapolis, MN), CD3 APC-AF750 (IOTest, Beckman Coulter, Brea, CA), CD8 Pacific Blue (IOTest, Beckman Coulter, Brea, CA), or CD45 Krome Orange (IOTest, Beckman Coulter, Brea, CA), corresponding to fluorescent channels FL1-FL10, respectively, for the generation of a compensation matrix.
+ Open protocol
+ Expand
3

Intracellular STAT1 Kinetics by FACS

Check if the same lab product or an alternative is used in the 5 most similar protocols
Intracellular pSTAT1 and total STAT1 kinetics were determined by FACS analysis. 50 µl whole blood was stimulated according to BD Phosflow™ T Cell Activation Kit Instruction Manual in polystyrene round-bottom tubes (Becton Dickinson Falcon). Blood was stimulated with Imukin® 100ng/ml for 0–180min at 37°C. Erythrocytes were lysed and leucocytes fixed with 1 ml of pre-warmed 1x lyse/fix buffer. The cells were then permeabilized by adding 300 µL of cold perm buffer III on ice for 30 min, stained with 750 µl stain buffer and incubated for 1 h in the dark at 4°C with following antibodies: anti-human CD14-FITC (BD Biosciences 345784), isotype STAT normal mouse IgG2a Alexa Fluor® 647 (Santa Cruz Biotechnology sc-24637) and Alexa Fluor® 647 mouse Anti-Stat1 (pY701) (BD Biosciences 612597). For Th1 and Th17 percentages PBMCs were stained with CD3 – BV605 (Biolegend), CD4 - APC-eFluor780 (eBioscience), CD8 – BV650 (eBioscience), CXCR3 – FITC (BioLegend), CCR6 – PE-Cy7 (BioLegend), CD45RA – PerCP (eBioscience) GZMB - e450 (BioLegend), CFSE - Invitrogen. All data were collected with LSR II (Becton Dickinson) and analyzed with FlowJo software (Treestar, Ashland, OR, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!